Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 8/2010

01-09-2010 | Original Articles

The C282Y polymorphism of the hereditary hemochromatosis gene is associated with increased sex hormone-binding globulin and normal testosterone levels in men

Authors: B. B. Yeap, MD, J. Beilin, Z. Shi, M. W. Knuiman, J. K. Olynyk, S. A. P. Chubb, D. G. Bruce, E. A. Milward

Published in: Journal of Endocrinological Investigation | Issue 8/2010

Login to get access
Metadata
Title
The C282Y polymorphism of the hereditary hemochromatosis gene is associated with increased sex hormone-binding globulin and normal testosterone levels in men
Authors
B. B. Yeap, MD
J. Beilin
Z. Shi
M. W. Knuiman
J. K. Olynyk
S. A. P. Chubb
D. G. Bruce
E. A. Milward
Publication date
01-09-2010
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 8/2010
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/BF03346645

Other articles of this Issue 8/2010

Journal of Endocrinological Investigation 8/2010 Go to the issue

Original Articles

Adiponectin-leptin ratio: A useful estimate of insulin resistance in patients with Type 2 diabetes

Original Articles

Prevalence of growth hormone deficiency in adult polytransfused β-thalassemia patients and correlation with transfusional and chelation parameters

Original Articles

Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese

Short Review

Medical therapy of acromegaly in Turkey

Opinion

Search for genetic mutations in cytological samples from thyroid nodules as a diagnostic tool: Reality, hope or myth?

Short Review

Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits